Sharda Cropchem Limited has informed the Exchange regarding a press release dated May 14, 2025, titled "Media Release on Audited Financial Results for the quarter and financial year ended March 31, 2025".
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharda Cropchem reported strong FY25 results with consolidated revenue growing 37% year-on-year to Rs. 4,320 crore, driven by 44% volume growth in agrochemicals. Q4 FY25 revenue rose 39% YoY to Rs. 1,829 crore. Profitability improved sharply with FY25 EBITDA more than doubling to Rs. 682 crore (margin expanding from 10.1% to 15.8%), and PAT jumping 854% YoY to Rs. 304 crore. The agrochemical segment grew 43% to Rs. 3,773 crore, led by herbicides (+52%) and strong contributions from Europe (+45%) and NAFTA (+49%). The Board recommended a final dividend of Rs. 6 per share (60% of face value), while the company remains debt-free with Rs. 558 crore in cash and liquid investments.
Strong double-digit revenue growth, sharp margin expansion, and a healthy dividend signal robust operational performance likely to be viewed positively by investors. Forward guidance of over 15% topline growth and Rs. 400-450 crore capex for FY26 suggests management confidence in sustained momentum.